Pacific Biosciences of California, Inc. Deferred Tax Assets, Tax Deferred Expense
Pacific Biosciences of California, Inc. (PACB) had Deferred Tax Assets, Tax Deferred Expense of $14.08 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpense · last filed 2026-02-25
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense $14.08M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense $10.51M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense $16.87M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense $13.83M; Deferred Tax Assets, Tax Deferred Expense as first filed $18.42M.
| Period end | Deferred Tax Assets, Tax Deferred Expense | Deferred Tax Assets, Tax Deferred Expense as first filed |
|---|---|---|
| 2025-12-31 | $14.08M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $10.51M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $16.87M 10-K · filed 2025-03-17 | |
| 2022-12-31 | $13.83M 10-K · filed 2024-02-28 | $18.42M 10-K · filed 2023-02-28 |
| 2021-12-31 | $10.82M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $6.34M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $8.02M 10-K · filed 2021-02-26 | |
| 2018-12-31 | $4.77M 10-K · filed 2020-02-28 | $19.36M 10-K · filed 2019-02-26 |
| 2017-12-31 | $14.48M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $20.09M 10-K · filed 2018-02-26 | |
| 2015-12-31 | $20.39M 10-K · filed 2017-03-06 | |
| 2014-12-31 | $21.74M 10-K · filed 2016-03-11 | |
| 2013-12-31 | $7.39M 10-K · filed 2015-03-12 | |
| 2012-12-31 | $5.68M 10-K · filed 2014-03-14 | |
| 2011-12-31 | $6.20M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |